Integrating Insulin Resistance Remission into
Ayurvedic Practice
Awaken Radiant Health For 40%–50% of the Western World
The Silent Pathway: From Root Cause to Manifest Disease
The most visible conditions — what people present with — sit at the top. The causal chain descends to its root at the bottom.
Why Insulin Resistance Changes Everything
Because insulin acts on every cell in the body continuously, insulin resistance is uniquely systemic — it is the shared upstream driver of the conditions listed above. Resolving it at the root can make all other interventions, including Ayurvedic ones, significantly more effective.
"Insulin resistance is the root cause of many heart conditions."
Dr. Pradip Jamnadas MD, FACC · Yale-trained Interventional Cardiologist
"Insulin resistance is not a benign condition. It is the tip of a major iceberg in health."
Dr. William Davis MD · Preventive Cardiologist, Author of Wheat Belly
"IR is the cornerstone of a unifying theory of chronic disease."
Dr. Jason Fung MD · Co-founder, Intensive Dietary Management Programme, Toronto
The Clinical Blind Spot: What Pulse Diagnosis Cannot Reach
Pulse diagnosis is highly refined — it detects real imbalance. But it cannot identify the biochemical driver beneath it. The diagram below shows both pathways rising from the same root.
When a pulse reading detects an imbalance, it is worth asking: could insulin resistance be the root cause? If so, reversing IR through a no-grains diet with intermittent fasting — tailored to the client's constitutional type — may resolve the imbalance at its source, rendering the symptomatic intervention unnecessary.
A fasting and dietary protocol suited to the client's constitutional type is applicable to the vast majority of clients, and may be the most powerful single intervention available.
The proven approach to reversing insulin resistance centres on eliminating grains — not only because grains drive rapid insulin spikes, but because they trigger the release of zonulin, disrupting tight junctions in the gut wall. This allows lipopolysaccharides and incompletely digested fragments into the bloodstream, driving systemic inflammation and arterial plaque formation — compounding the cardiovascular risk that IR already creates.
The case against high-carbohydrate diets is almost always made on blood sugar grounds alone. The gut integrity mechanism is equally important — and almost entirely absent from mainstream dietary discussion.
Carbohydrates — especially refined grains and sugars — cause rapid, repeated blood glucose spikes. Each spike demands an insulin response. Over years, cells progressively downregulate their insulin receptors in self-defence, producing insulin resistance. Removing dietary carbohydrate breaks this cycle directly, reducing insulin demand and allowing receptor sensitivity to recover.
Grains — independently of their glycaemic effect — trigger the release of zonulin, a protein that disrupts the tight junctions between cells lining the gut wall. This causes intestinal permeability (leaky gut), allowing lipopolysaccharides, incompletely digested food proteins, and microbial fragments to pass into the bloodstream. The resulting systemic immune activation drives chronic low-grade inflammation, arterial plaque formation, and compounds the cardiovascular risk that insulin resistance already creates. This mechanism operates even in people who show no digestive symptoms.
The Integration: Ayurveda & Metabolic Science
Two frameworks — converge toward one integrated outcome.
Between 40 and 60% of Western adults carry some degree of insulin resistance — the most prevalent undiagnosed chronic condition in the Western world, and the upstream driver of most of the diseases Ayurvedic practitioners are already treating. Conventional medicine addresses these conditions symptom by symptom, with pharmaceutical interventions that manage the downstream manifestation while leaving the root cause entirely untouched.
The Ayurvedic constitutional model offers exactly what a one-size-fits-all nutritional protocol cannot: the nuance to predict how a Kapha-dominant person will present differently from a Vata-dominant person with the same HOMA-IR score, and to tailor the intervention accordingly. Adding a HOMA-IR test as a near-universal intake assessment — complementing, not replacing, pulse diagnosis — closes the one significant gap in an already profound clinical framework.
In the UK, up to 55% of adults — an estimated 30 million people — are mostly living with undetected insulin resistance.
An Alternative Window: The Triglycerides / HDL Ratio
For practitioners and clients who cannot immediately access a HOMA-IR test, there is a second, highly informative marker available from any standard lipid panel: the Triglycerides / HDL (High-Density Lipoprotein) ratio. This ratio has been validated as a clinical proxy for insulin resistance, reflecting the same underlying metabolic dysfunction that a HOMA-IR score measures — through a different biochemical lens.
When triglycerides rise and HDL falls simultaneously, the ratio worsens rapidly — amplifying a signal that either marker alone would understate. A ratio above 3.0 in a non-diabetic adult is one of the most accessible and reliable indicators that insulin resistance is already present.
The TG/HDL ratio is particularly relevant because a low-carbohydrate diet — the primary dietary intervention for reversing insulin resistance — directly and measurably improves both components of this ratio simultaneously. This creates a highly practical feedback loop: the same dietary change that addresses the root cause also produces visible, testable improvements in the ratio within weeks.
A 2024 meta-analysis of 17 randomised controlled trials encompassing 1,197 participants found that low-carbohydrate diets produced significant reductions in triglycerides and significant increases in HDL cholesterol, without adverse effects on LDL or total cholesterol — confirming that the dietary intervention directly improves both components of this ratio. [Reference 6]
A further meta-analysis of 12 randomised trials (PLOS One, 2020) confirmed that low-carbohydrate diets reduced triglyceride levels consistently across intervention periods of up to two years, with HDL rising in parallel — driven by lower insulin levels, increased fat oxidation, and improved lipoprotein particle distribution. [Reference 7]
Used alongside HOMA-IR, the TG/HDL ratio provides a complementary metabolic picture — one that is already present in routine blood work, requires no additional test, and gives clients an immediately interpretable number that improves visibly and quickly with dietary change. For motivating sustained compliance, this accessibility is clinically valuable.
Insulin Resistance & the Seven Dhatus
A Convergence of Ancient and Modern Understanding
In Ayurveda, every disease begins with a weakening of Agni — the metabolic fire operating at every level, from the gut (Jatharagni) to each tissue (Dhatvagni). When Agni is chronically disturbed, improperly transformed material produces Ama — a sticky, toxic residue that accumulates in the channels (Srotas), blocks cellular communication, and becomes the seed of systemic disease. Insulin resistance, in this framework, is fundamentally an Agni disorder — a failure of Dhatvagni spreading progressively through the Dhatu sequence.
The cell's inability to receive and process glucose is a failure of tissue-level metabolic fire spreading progressively through the Dhatu chain. Ama introduced early in the chain corrupts everything downstream — a principle that maps precisely onto the modern understanding of how insulin resistance propagates through organ systems over years and decades.
This is the first tissue nourished after digestion. In a healthy state, Rasa carries pure nourishment and maintains Vyadhikshamatva (immune resilience) throughout the body. In insulin resistance, impaired Jatharagni produces Ama that immediately enters Rasa — mapping precisely to the chronic low-grade inflammatory signalling seen in elevated cytokines (TNF-alpha, IL-6), dysregulated adipokines, and disordered blood glucose that circulate systemically before overt disease appears. Rasa becomes turbid and Ama-laden, compromising its ability to nourish all downstream tissues.
Ama in Rakta manifests as oxidative stress, endothelial inflammation, and dyslipidaemia — the exact processes modern research links to early cardiovascular risk in insulin resistance. The blood vessels become sticky and reactive. The Rakta Srotas become coated with Ama, impairing their ability to carry Prana and clear metabolic waste. This is the beginning of atherosclerosis — Rakta Dushti.
Skeletal muscle is the primary site of glucose disposal in the body. In insulin resistance, muscle cells lose their responsiveness to insulin — Mamsa Dhatvagni is suppressed. The muscle cannot properly receive or metabolise glucose, contributing to rising blood sugar and forcing the pancreas to overproduce insulin. Ama blocks the Mamsa Srotas, preventing proper nourishment and the functional integrity of the tissue.
Meda Dhatu's own Agni (Meda Dhatvagni) becomes severely impaired. Adipose tissue expands abnormally — especially visceral fat — and becomes infiltrated by inflammatory M1 macrophages. It begins secreting pro-inflammatory adipokines (leptin, resistin, chemerin) rather than anti-inflammatory ones (adiponectin), and free fatty acids flood the bloodstream. This is Meda Vriddhi — excess and pathological Meda — combined with deep Ama accumulation. Since Meda nourishes the three deeper, more subtle Dhatus, its corruption now sends Ama-laden nutrition downward into them.
Chronic inflammation and metabolic imbalance from corrupted Meda now begin affecting bone density and joint integrity. Modern research confirms that insulin resistance is associated with increased fracture risk, inflammatory arthritis, and degraded bone metabolism. The Asthi Srotas receive improperly formed Meda nutrition, and Asthi Dhatvagni cannot build healthy bone tissue — producing instead fragile, inflamed skeletal structures.
This is where the immune connection becomes most profound — modern science and Ayurveda converge dramatically here. Bone marrow is where immune cells are born. When Majja Dhatu receives Ama-corrupted nourishment, immune cell precursors (monocytes, lymphocytes, NK cells) develop with intrinsic dysfunction, emerging already skewed toward inflammatory, poorly regulated behaviour. This maps directly to research showing T cells, B cells, macrophages, and NK cells all shifting toward pro-inflammatory states. At the nervous system level, the neurological complications of long-term insulin resistance — neuropathy, cognitive decline, the Alzheimer's connection — represent Ama in Majja Dhatu.
The seventh and most refined Dhatu represents the distilled essence of all previous transformations. From Shukra/Artava comes Ojas — the master substance of immunity and vitality in Ayurveda; what modern science might call the immune system's integrated capacity to respond appropriately and maintain tolerance. When all six preceding Dhatus are corrupted, Ojas production fails — manifesting as loss of Vyadhikshamatva, autoimmune dysregulation, cancer vulnerability, and profound fatigue. This is precisely what research describes: immune cells that are chronically inflamed, unable to mount proper responses, and unable to maintain regulatory balance.
A core Ayurvedic principle: as Ama increases, Ojas decreases. The research confirms this with striking precision.
| Ama Accumulation | Ojas Depletion |
|---|---|
| Chronic low-grade inflammation | Weakened immune resilience |
| Cytokine excess (TNF-alpha, IL-6) | Loss of immune regulation |
| Macrophage M1 polarisation | Failure of immune tolerance |
| Blocked Srotas | Impaired cellular communication |
| Progressive organ damage | Vulnerability to cancer, infection & autoimmunity |
What Ayurveda offers that modern medicine is only recently catching up to is the understanding that this is a whole-system, sequential, progressive corruption — not a collection of separate diseases. Type 2 diabetes, heart disease, Alzheimer's, cancer, and immune failure are not independent conditions; they are the downstream expressions of the same upstream impairment of Agni and the same accumulation of Ama moving through the Dhatu chain.
The modern research essentially confirms what Ayurveda mapped thousands of years ago: treat the Agni, clear the Ama, and protect the Ojas — before the corruption reaches the deeper tissues where reversal becomes far more difficult.
This systematic review and meta-analysis of 10 randomised controlled trials involving 701 adults with metabolic syndrome found that intermittent fasting significantly reduced fasting blood glucose, insulin levels, HOMA-IR, and HbA1c — all primary markers of insulin resistance — with high-quality GRADE evidence for each outcome. HOMA-IR decreased by a standardised mean difference of −0.39. The authors conclude that intermittent fasting produces improvement in glycaemic control and insulin sensitivity comparable to pharmaceutical insulin sensitisers, but without the associated side effects.
This comprehensive review maps how the insulin receptor is expressed across all major immune cell types and shapes their behaviour. It documents how chronic hyperinsulinaemia drives immune cells to become insulin-resistant themselves, undermining both protective immunity and immune tolerance. It specifically connects these mechanisms to type 2 diabetes, cancer susceptibility, and increased vulnerability to infections including COVID-19.
This study details how insulin resistance shifts macrophages, T cells, B cells, and NK cells into chronic pro-inflammatory states. It examines how dysregulated adipokines like leptin and resistin drive immune polarisation, and how the resulting inflammation creates a self-reinforcing cycle that drives beta-cell destruction. It argues that addressing immune dysfunction — not just blood sugar — is essential for comprehensive diabetes management.
Researchers analysed 43 immune activation markers in 150 volunteers and identified a distinct immune profile strongly correlated with insulin resistance and metabolic syndrome. This profile was characterised by CD4+ T cell ageing, B cell activation, and elevated inflammatory markers like TNF-alpha. The study suggests this immune signature could serve as an early screening tool to identify people at risk for metabolic disease before full diabetes develops.
This paper explores how insulin resistance in the context of obesity accelerates immune ageing (immunosenescence), causing immune cells to prematurely lose their protective capacity. Senescent immune cells secrete pro-inflammatory compounds that damage surrounding tissues, creating a vicious cycle linked to cardiovascular disease, Alzheimer's, and autoimmune conditions.
This meta-analysis of 17 RCTs encompassing 1,197 participants demonstrated that low-carbohydrate diets significantly reduced triglycerides and increased HDL cholesterol — without affecting LDL or total cholesterol. Weight loss, reduced BMI, lower diastolic blood pressure, and decreased waist circumference were additional benefits. The authors identify reduced insulin levels as the key mechanism: lower insulin decreases inhibition of hormone-sensitive lipase, promoting triglyceride breakdown, while improved insulin sensitivity enhances HDL production and function.
A meta-analysis of 12 randomised controlled trials found that low-carbohydrate diets consistently reduced triglyceride levels across multiple time periods — with reductions observed at under 6 months, at 12–23 months, and beyond — alongside a sustained increase in HDL cholesterol. Blood pressure, fasting blood glucose, and body weight also improved. The analysis confirms that the lipid benefits of a low-carbohydrate diet are durable across intervention periods of up to two years.